INcontrol And The BioGienie - Fort Richard Laboratories Ltd
INcontrol And The BioGienie - Fort Richard Laboratories Ltd
INcontrol And The BioGienie - Fort Richard Laboratories Ltd
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>INcontrol</strong> <strong>And</strong> <strong>The</strong><br />
<strong>BioGienie</strong><br />
.
History<br />
• <strong>INcontrol</strong>, supports a range of infection<br />
control products supported across<br />
Australasia by <strong>Fort</strong> <strong>Richard</strong> <strong>Laboratories</strong><br />
<strong>Ltd</strong> and Able Scientific.
Backed by renowned companies<br />
in Australia and New Zealand<br />
• <strong>Fort</strong> <strong>Richard</strong> – a family business with facilities in<br />
Auckland & Melbourne operating since 1974<br />
specializing in the manufacture and supply of culture<br />
media and related microbiology consumables to<br />
clinical laboratories/hospitals throughout new<br />
Zealand and Australia. Many years experience in<br />
supplying products for the surveillance of HAI’s.<br />
• Able Scientific – a family business based in Perth WA<br />
since 1990 supplying Life Science/biotechnology<br />
products to Animal Research Facilities/Universities<br />
throughout Australasia.
Global alliances in Healthcare<br />
• <strong>Fort</strong> <strong>Richard</strong> acquired the Biogenie agency for Australasia<br />
following contact with parent company Hygienics<br />
Biosecurity at Medica 2009, recognizing the need to move<br />
into prevention of HAI’s as well as surveillance.<br />
• In order to best serve both Australia and New Zealand <strong>Fort</strong><br />
<strong>Richard</strong> has partnered with Able Scientific to represent the<br />
Biogenie and several infection control products already<br />
distributed by Able Scientific. This range of products forms<br />
our brand <strong>INcontrol</strong>.<br />
• Personnel from both companies received extensive training<br />
on the Biogenie at Alton, UK in April 2010.<br />
• Through our network of distribution facilities in Auckland,<br />
Melbourne, and Perth, we will provide the ultimate in<br />
service and support across Australasia.
<strong>And</strong> now, let us introduce the<br />
<strong>BioGienie</strong>
<strong>BioGienie</strong> - prevention is<br />
better than cure<br />
• <strong>The</strong> most technologically advanced yet simpleto-use<br />
decontamination system on the market<br />
today.<br />
• Built on the successful history of H2O2 room<br />
decontamination by utilizing lower-risk<br />
disinfectant (meaning a much more portable<br />
and available system), easy-to-use intuitive<br />
software, light and maneuverable design<br />
features, and a more effective kill due to the<br />
ionized and nucleated dry-mist vapor.<br />
• All this combines to deliver an affordable inhouse<br />
decontamination system previously<br />
unavailable to healthcare organizations.
<strong>The</strong> Problem – HAI (Healthcare<br />
Acquired Infection) -<br />
• HAI’s cost aproximately $1 billion each<br />
year*<br />
– 175,000 patients infected whilst in hospital<br />
each year<br />
• 5 days extra days in hospital<br />
• A patient costs $2 - 20k extra to treat<br />
• Litigation increasing<br />
• ~20% mortality<br />
• A very emotive subject
<strong>The</strong> Problem – HAI (Healthcare<br />
Acquired Infection)<br />
• Common Pathogens include:<br />
• MRSA<br />
• Clostridium Difficile *<br />
• Acinetobacter<br />
• Norovirus<br />
• VRE/ESBL
<strong>The</strong> Problem – HAI (Healthcare<br />
Acquired Infection) - Australia<br />
• A report released by professor Graves in<br />
September 2009 estimates that “the<br />
annual direct cost of treating HAI<br />
(Hospital Acquired infections) was close<br />
to $1 billion, and that improving<br />
infection control could save roughly<br />
$600 million”
<strong>The</strong> Problem – HAI (Healthcare<br />
Acquired Infection) - Australia<br />
• Latest news in Australia has the press saying “A stomach<br />
bug that has killed thousands in Canada, USA, Britain &<br />
Europe has been found in Australia. It is known as “the<br />
Quebec strain of Clostridium difficile’ & does not respond<br />
to the alcoholic hand cleanser now used throughout<br />
Australia’s hospitals. A full hand wash with disinfectant<br />
soap & water, isolation of patients & disinfecting wards is<br />
required to prevent it spreading. Australia is ill-prepared if<br />
there is a spread from the 3 patients confirmed in<br />
Melbourne’s Epworth hospital. Only two laboratories in<br />
Australia - In Sydney & Perth – can positively identify this<br />
serious bug, but moves are afoot to enable<br />
microbiologists in each state to rapidly identify any<br />
outbreak.”
Our Solution – Biogienie<br />
• A Hydrogen Peroxide Dry Mist Vapour<br />
Robot<br />
– Effective<br />
– Safe<br />
– Simple to Use<br />
– Inexpensive
Decontamination - Challenges<br />
– Normal cleaning methods not enough<br />
• Limited effectiveness<br />
• Pathogen resistance<br />
• Recontamination<br />
• Costly Downtime<br />
– High risk alternatives<br />
• Ozone gas<br />
• Ethylene oxide gas<br />
• High concentration H2O2 vapour<br />
RECURRENT CYCLE<br />
OF CONTAMINATION<br />
SURFACE<br />
AIR
Effective<br />
• Clinically proven against major pathogens<br />
(spores, bacteria, viruses and fungi)<br />
• Ionised & nucleated dry mist<br />
– Very efficient dispersal of disinfectant<br />
– Smaller dry zone than competitors<br />
• Single unit decontaminates 4m³ - 200m³<br />
– Multiple units used for larger areas
• Biocidal disinfectant<br />
Safe<br />
– Uses Hyproxil Active - 6% H2O2 / 60ppm Ag+<br />
• Much lower H 2O 2 level then competitors (can be<br />
>30%)<br />
• Complies with EEC 98/8 standard<br />
• Eliminates Bio Immunity<br />
• Clinically proven results<br />
• Sealed recyclable cartridges<br />
– Avoids risk of spillage<br />
– Environmentally responsible
• Built in Safety<br />
• Clear warning lights<br />
Safe<br />
• Safety sensors monitor key areas e.g. liquid leak<br />
• Light and manoeuvrable<br />
• Weighs just 39kg<br />
• Built for ease of movement<br />
• Operator friendly<br />
• User panel at optimum height<br />
• Easy to load Hyproxil Active<br />
cartridge
Simple to use<br />
• Program via colour touch screen<br />
– Set operation for :<br />
• Flow rate allows room sizes from 4 m³ to 200 m³<br />
• Number of ml per m³ dosage<br />
• Level of concentration (valuable for pathogen<br />
variants)<br />
• Pre-programmed rooms (quick set up)<br />
– Multi–level security and downloadable audit trail
Inexpensive<br />
• For the cost of approximately 3 HAI<br />
cases, you can own a Biogienie.<br />
• We have a flexible approach to<br />
ownership offering, outright buy, rent-toown,<br />
and rental.<br />
• Ongoing consumable costs from $625.00<br />
per 2000 m3 of room space<br />
decontaminated
Some Current <strong>BioGienie</strong> Users<br />
National Blood Service
Biogienie - the Internationally<br />
proven solution<br />
Nottingham University Hospitals NHS Trust<br />
“50% reduction in C.diff rates since introduction Dry Mist HPV”<br />
University Hospitals of Leicester NHS Trust<br />
“Major contributor to 65% reduction in C.diff rates”<br />
Kettering General Hospital NHS Trust<br />
“Substantial reduction in patients relapsing with C.diff in isolation<br />
rooms since introducing Dry Mist HPV”<br />
Sandwell Hospital, Birmingham<br />
“After vaporisation we had big reductions in incidences of recurrent<br />
C.diff”<br />
Southend Teaching Hospitals NHS Trust<br />
“Prior to the use of Dry Mist HPV micro-organisms were noted.<br />
Post Dry Mist HPV no micro-organisms were noted after 48 hours”
Biogienie - backed by clinical studies<br />
• In a recent study, hydrogen peroxide vapour<br />
decontamination was 82% more effective at eradicating C.<br />
difficile than conventional wiping and disinfecting using<br />
hypochlorite.<br />
• A Journal of Hospital Infection study of MRSA showed that<br />
after conventional terminal cleaning, 66% of 124 swabs<br />
yielded MRSA (74% by direct plating), while after hydrogen<br />
peroxide vapour decontamination, only 1 of 85 swabs<br />
yielded MRSA (by enrichment culture only).<br />
• Another study showed 100% elimination of C. difficile<br />
contamination after hydrogen peroxide vapour<br />
decontamination.<br />
• Over half of the UK hospitals have purchased the Biogienie<br />
and attribute a 50% reduction in HAI’s to the use of this<br />
system.
Results: C difficile<br />
C difficile NCTC 11209<br />
C difficile NCTC 11223<br />
C difficile NCTC 11382<br />
Clinical isolates (n=8)<br />
Typical kill rates<br />
4 x 10 6 – 1.8 x 10 7<br />
1.E+08<br />
1.E+07<br />
1.E+06<br />
1.E+05<br />
1.E+04<br />
1.E+03<br />
1.E+02<br />
1.E+01<br />
1.E+00<br />
Pre-exposure<br />
Post-exposure<br />
NCTC 11209 NTCT 11223 NCTC 11382 Clinical isolates<br />
(n=8)
Summary<br />
• <strong>BioGienie</strong> - Next generation technology<br />
– Effective<br />
– Safe<br />
– Simple to Use<br />
– Inexpensive<br />
Available Now